Wehbe, M., Lo, C., Leung, A. W. Y., Dragowska, W. H., Ryan, G. M., & Bally, M. B. (2017). Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status. Invest New Drugs.

Wehbe, Mohamed, Cody Lo, Ada W. Y. Leung, Wieslawa H. Dragowska, Gemma M. Ryan, and Marcel B. Bally. "Copper (II) Complexes of Bidentate Ligands Exhibit Potent Anti-cancer Activity Regardless of Platinum Sensitivity Status." Invest New Drugs 2017.

Wehbe, Mohamed, et al. "Copper (II) Complexes of Bidentate Ligands Exhibit Potent Anti-cancer Activity Regardless of Platinum Sensitivity Status." Invest New Drugs 2017.